Eur Respir J 2010; 35:353-360 Copyright ©ERS Journals Ltd 2010 doi: 10.1183/09031936.00184908
The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis1 Clinique des Maladies Respiratoires, 2 Service d'Explorations Fonctionnelles Respiratoires, and 3 Service de Neurologie A, CHRU, Lille, France. CORRESPONDENCE: N. Just, Service de Pneumologie, Hôpital Victor Provo, 11-17 Bd Lacordaire, F-59100 Roubaix Cedex, France. E-mail: nicolas.just{at}ch-roubaix.fr Keywords: Amyotrophic lateral sclerosis, Borg scale, respiratory muscle strength
Received: December 5, 2008
The aim of the study was to determine whether the Borg dyspnoea scale could be a useful and simple marker to predict respiratory muscle weakness in amyotrophic lateral sclerosis (ALS).
From April 1997 to 2001, respiratory function was perfomed in 72 patients together with the Borg score in both the upright (uBorg) and supine (sBorg) positions.
Mean upright vital capacity (VC) was 81±24% predicted, sniff nasal inspiratory pressure (SNIP) was 55±26% pred, maximal inspiratory pressure (PI,max) was 57±26% pred and arterial carbon dioxide tension (Pa,CO2) was 41±6 mmHg. The mean Borg scores in the upright and supine positions were 1.7±1.5 and 2.2±2, respectively. A significant relationship between SNIP and uBorg (r = 0.4; p = 0.0007) and SNIP and sBorg (r = 0.58; p<0.0001) was observed. Upright VC,
The Borg dyspnoea scale is a valuable noninvasive test for the prediction of inspiratory muscle weakness in ALS patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||